R&D expense · 2016–2025
Guardant Health R&D expense
$364M+4.7% · FY2025
Guardant Health (GH) reported $364M in R&D expense for fiscal 2025, +4.7% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $364M | +4.7% | Open → |
| FY20242024-12-31 | $348M | −5.3% | Open → |
| FY20232023-12-31 | $367M | −1.8% | Open → |
| FY20222022-12-31 | $374M | +42.0% | Open → |
| FY20212021-12-31 | $263M | +75.6% | Open → |
| FY20202020-12-31 | $150M | +73.7% | Open → |
| FY20192019-12-31 | $86.3M | +70.2% | Open → |
| FY20182018-12-31 | $50.7M | +98.4% | Open → |
| FY20172017-12-31 | $25.6M | +135.4% | Open → |
| FY20162016-12-31 | $10.9M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +47.7%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Guardant Health R&D expense |url=https://companiesranked.com/en/company/guardant-health/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Guardant Health R&D expense. CompaniesRanked. https://companiesranked.com/en/company/guardant-health/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-guardant-health-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Guardant Health R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/guardant-health/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001576280-26-000013 · February 19, 2026
{{cite web |title=Guardant Health R&D expense — 10-K (0001576280-26-000013) |url=https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.